NEW

Epigenomics of Common Diseases

14–17 November 2017

Wellcome Genome Campus, Hinxton, UK

Summary

The 7th Epigenomics of Common Diseases conference will bring together leading scientists for the fields of epigenomics, genetics and bioinformatics to discuss the latest developments in this fast-moving area.

Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention and treatment. Technological advancements in the past few years have fuelled a dramatic increase in the scale, breadth and availability of epigenomic reference data. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established.

This meeting will focus on epigenomic studies across of a wide range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease. This year’s meeting will emphasise recent studies on epigenetics of ageing, brain diseases, chromatin architecture, regulatory networks, and computational epigenomics. There will also be a special session on the approaches needed to demonstrate causality in epigenetic studies.

 

Programme

The conference will start at approximately 12.30 on Tuesday, 14 November and close at approximately 14.00 on Friday, 17 November 2017.

Topics will include:

  • Epigenomics of ageing
  • Evolution and epigenetics
  • Inheritance of epigenetic programmes
  • Population and clinical epigenetics
  • Epigenomics of brain disease
  • Causality in epigenetic studies
  • 4D nucleome
  • Enhancers and regulatory networks
  • Computational epigenomics and bioinformatics
  • New epigenomic technologies

Click here for the conference programme.

Organisers and speakers

Scientific programme committee
Edith Heard Institut Curie, France
Doug Higgs
University of Oxford, UK
Caroline Relton
University of Bristol, UK
Art Petronis
University of Toronto, Canada

Keynote speakers
Genevieve Almouzni Institut Curie, France
Wendy Bickmore University of Edinburgh, UK

Confirmed Speakers
Peter Adams University of Glasgow, UK
Ewan Birney
EMBL-EBI, UK
George Davey-Smith
University of Bristol, UK
Mandy Fisher
MRC Clinical Sciences Centre, UK
Anja Groth
University of Copenhagen, Denmark
Bas Heijmans
Leiden University Medical Center, The Netherlands
Doug Higgs
University of Oxford, UK  
Steve Horvath
University of California, Los Angeles, USA 
Nada Jabado
Montreal Childrens Hospital, Canada
Tomas Marques-Bonet
Universitat Pompeu Fabra, Spain
Matthias Merkenschlager MRC Clinical Sciences Centre, UK   
Marcelo Nobrega
University of Chicago, USA
Duncan Odom 
Cancer Research UK Cambridge Institute, UK
Tomi Pastinen Children’s Mercy Kansas City, USA   
Tatjana Sauka Spengler
University of Oxford, UK
Anne Schaefer
Mount Sinai School of Medicine, USA

Conference organiser
Laura Hubbard Wellcome Genome Campus, UK

How to apply

Registration Fees:

Student No accommodation £365
Student On site twin accommodation £517
Student On site single accommodation £610
Academic No accommodation £465
Academic On site twin accommodation £617
Academic On site single accommodation £710
Commercial No accommodation £565
Commercial On site twin accommodation £717
Commercial On site single accommodation £810

 

The registration fee includes entrance to the lectures and poster
sessions, an abstract book, meals (lunch and dinner) and refreshments
during the conference. Breakfast will be provided for delegates who have
booked accommodation.

Registration closed

Accommodation
Accommodation is provided for the nights of 14, 15 16 November 2017.
Please note: there is limited onsite accommodation and this will be
allocated on a first-come, first-served basis. Therefore, early
registration is recommended.

If you wish to book onsite accommodation either side of the conference
dates, please contact the Conference Centre directly.

Travel visas
Contact the conference organiser if you require a letter to support a
travel visa application. Please note: letters will only be provided to
confirmed registrants.

Non-European Economic Area or Swiss nationals may be required to have a
visa to enter the UK.
Early application is strongly advised, as this process can take 6-8 weeks
or longer.

Please visit the following websites for further information:
UK Border Agency website: www.ukba.homeoffice.gov.uk/visas-immigration/

Information for general visitors and business visitors: www.ukba.homeoffice.gov.uk/visas-immigration/visiting/business/business-activities/

Cost

A limited number of registration bursaries are available for PhD students to attend this conference (up to 50% of the registration fee) from Wellcome Genome Campus Scientific Conferences.

The following documents will need to be provided:

  • Abstract
  • CV
  • Covering letter
  • Letter from supervisor

To apply, please contact the conference organiser.

Bursary deadline: Closed

Abstracts

We welcome abstracts from all areas relevant to the main themes of the meeting, for both oral and poster presentations. Several oral
presentations will be chosen from the abstracts submitted.

Abstracts will only be considered from registered delegates. Please use our online abstract submission system and follow the instructions given to ensure your abstract is submitted correctly. All abstracts must be submitted by the deadline. If you are intending to submit more than one abstract, please contact the conference organiser prior to registration.

The scientific programme committee will assess your abstract after the deadline has passed and you will be notified whether you have been selected for an oral or poster presentation.

Poster boards onsite will accommodate 118 cm high by 84 cm wide (A0-portrait) of printed material. Accepted abstracts will appear in the conference programme book and poster boards will be allocated at the conference.

Abstract deadline: Closed

Abstract guidelines can be viewed here.

Back to top Back to top